Primary Record
Epirubicin
- In stock
- 1,387 g
- Purity
- 98.1 %
- CAS
- 56420-45-2
Compound Identifiers & Properties
- CAS
- 56420-45-2
- PubChem CID
- 41867
- SMILES
- C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1
Names & Synonyms
- Epirubicin
- Epiadriamycin
- Epidoxorubicin
- Epirubicine
- 4'-Epiadriamycin
- Epirubicina
- Ridorubicin
- 4'-epidoxorubicin
- Epirubicinum
- Farmorubicin
- Pidorubicina
- Pidorubicine
- Pidorubicinum
- Ellence
- Pidorubicin
- 4-Epidoxorubicin
- Pharmorubicin
- Epi-DX
- Epirubicine [French]
- Epirubicinum [Latin]
- doxorubicin
- epirarubicin
- farmarubicin
- farmarubicine
- pharmarubicin
- Epirubicina [Spanish]
- Farmorubicine
- Pharmorubicin Pfs
- Epi-doxorubicin
- 56420-45-2
- Epirubicin free base
- 4'-epi-Doxorubicin
- Epirubicin HCl
- Epirubicin hydrochloride
- EPIcell
- Epirubicin (INN)
- Farmorubicin (TN)
- 4'-epi-Adriamycin
- Epirubicin [INN:BAN]
- Epirubicine [INN-French]
- Epirubicinum [INN-Latin]
- Triferric doxorubicin
- 4' Epiadriamycin
- EPI cell
- Epirubicin (TN)
- Epirubicina [INN-Spanish]
- Pidorubicine [INN-French]
- Pidorubicinum [INN-Latin]
- 4' Epidoxorubicin
- Pidorubicina [INN-Spanish]
- Ellence (TN)
- IMI 28
- 4' Epi Adriamycin
- Epi DX
- Pharmorubicin (TN)
- 4'-Epi-DXR
- 4' Epi Doxorubicin
- Ebewe (TN)
- Epirubicinum (Latin)
- 4 -Epiadriamycin
- 4'-epi-DX
- 4 -Epidoxorubicin
- Acid, 8
- 4 -epi-Adriamycin
- 4 -epi-Doxorubicin
- EPIRUBICIN [MI]
- RefChem:55117
- 4'-epi DX
- AC1Q6JIV
- EPIRUBICIN [INN]
- 4' Epi DXR
- CCRIS 2261
- EPIRUBICIN [HSDB]
- EPIRUBICIN [VANDF]
- CHEMBL417
- D0C9XJ
- HSDB 6962
- UNII-3Z8479ZZ5X
- AC1L26NP
- SCHEMBL8582
- AOJJSUZBOXZQNB-VTZDEGQISA-N
- NSC-256942
- 3Z8479ZZ5X
- EPIRUBICIN [WHO-DD]
- N-METHYLDIETHANOLAMINE
- WP 697
- DTXSID0022987
- CHEBI:47898
- NSC 256942
- DTXCID202987
- IMI-28
- orb1740387
- EPIRUBICIN(Hydrochloride form)
- SCHEMBL29350836
- SCHEMBL29711855
- BDBM43839
- CTK8F9465
- BRN 1445813
- L01DB03
- NSC256942
- C27H29NO11
- Doxorubicin-13CD3 (discontinued)
- CID41867
- ZINC3938704
- BBF-05862
- EBC-27300
- WP-697
- C27-H29-N-O11
- 56420-45-2 (FREE BASE)
- ACN-038342
- CS-2824
- DB00445
- VA10821
- NCGC00263918-04
- NCGC00263918-06
- NCGC00263918-08
- AN-40147
- BP-43652
- HY-13624
- J81.933F
- LS-93992
- SBI-0206890.P001
- LS-187190
- 2020B
- NS00069619
- A12409
- C11230
- D07901
- (8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
- 15206-EP2269994A1
- 15206-EP2270008A1
- 15206-EP2270018A1
- 15206-EP2272827A1
- 15206-EP2275420A1
- 15206-EP2280012A2
- 15206-EP2281815A1
- 15206-EP2289892A1
- 15206-EP2292615A1
- 15206-EP2292617A1
- 15206-EP2295055A2
- 15206-EP2295416A2
- 15206-EP2295426A1
- 15206-EP2295427A1
- 15206-EP2298748A2
- 15206-EP2298764A1
- 15206-EP2298765A1
- 15206-EP2298768A1
- 15206-EP2298778A1
- 15206-EP2298780A1
- 15206-EP2301928A1
- 15206-EP2301933A1
- 15206-EP2305640A2
- 15206-EP2305642A2
- 15206-EP2305671A1
- 15206-EP2305689A1
- 15206-EP2308855A1
- 15206-EP2308861A1
- 15206-EP2311453A1
- 15206-EP2311808A1
- 15206-EP2311825A1
- 15206-EP2311827A1
- 15206-EP2311829A1
- 15206-EP2311840A1
- 15206-EP2311842A2
- 15206-EP2316832A1
- 15206-EP2316833A1
- AB00698552-11
- AB00698552-13
- AB00698552-14
- AB00698552_15
- AB00698552_16
- EN300-7410311
- A831042
- Q425122
- (8S,10S)-10-(((2R,4S,5R,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
- BRD-K04548931-003-13-2
- BRD-K04548931-003-16-5
- (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- 5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-
- (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside
- (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside
- (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione
- 23214-92-8
- 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
- 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
- (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSIDE
- (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-alpha-L-ARABINO-HEXOPYRANOSIDE
- (7S,9S)-7-((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- (8S)-10alpha-[(3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-8-(hydroxyacetyl)-7,8,9,10-tetrahydro-6,8alpha,11-trihydroxy-1-methoxy-5,12-naphthacenedione
- (8S)-8-(Hydroxyacetyl)-10alpha-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
- (8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
- (8S,10S)-10alpha-[(3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8beta-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
- (8S-cis)-10-((3-Amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
- 3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside
- 4'-Epidoxorubicin|||4'-Epiadriamycin|||(8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
- 5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, (8S-CIS)-
- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-
- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-
- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.beta.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
- 56390-09-1
- DM2
- DM6